Arena Pharmaceuticals, Inc.

Press Releases



All Releases

View Summary Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5
Jul 30, 2015
PDF 12.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals Initiates a Phase 2 Clinical Trial of APD334, its S1P1 Receptor Modulator for Autoimmune Diseases
Jul 29, 2015
PDF 13.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces the Departure of Chief Financial Officer
Jun 16, 2015
PDF 11.9 KB Add to Briefcase
View Summary Lorcaserin HCl Data to be Presented at American Diabetes Association's 75th Scientific Sessions
Jun 4, 2015
PDF 19.3 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference
May 26, 2015
PDF 11.3 KB Add to Briefcase
View Summary Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at Upcoming Medical Meetings
May 14, 2015
PDF 19.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2015 Financial Results
May 11, 2015
PDF 24.0 KB Add to Briefcase
View Summary Arena Pharmaceuticals and Roivant Sciences Enter into Collaboration for Nelotanserin, a Novel Inverse Agonist of the 5-HT2A Receptor
May 11, 2015
PDF 13.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference
May 8, 2015
PDF 11.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host First Quarter 2015 Financial Results Conference Call and Webcast on Monday, May 11
May 7, 2015
PDF 12.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals Reports Favorable Results from Phase 1 Single-Ascending Dose Clinical Trial of APD371
Apr 29, 2015
PDF 12.4 KB Add to Briefcase
View Summary Eisai and Arena Pharmaceuticals Complete Registrational Trials of an Extended Release Formulation of Lorcaserin
Apr 10, 2015
PDF 20.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Annual Needham Healthcare Conference
Apr 9, 2015
PDF 11.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals Receives Additional Patent for BELVIQ® (lorcaserin HCl) from United States Patent and Trademark Office
Apr 7, 2015
PDF 20.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2014 Financial Results
Mar 2, 2015
PDF 26.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast on Monday, March 2
Feb 23, 2015
PDF 12.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the 2015 RBC Capital Markets Healthcare Conference
Feb 18, 2015
PDF 11.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Marketing Approval in South Korea of BELVIQ® (lorcaserin HCl) for Weight Management
Feb 3, 2015
PDF 14.0 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference
Feb 2, 2015
PDF 11.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Agreement to Sell Common Stock
Jan 21, 2015
PDF 13.1 KB Add to Briefcase
Showing 21-40 of 515 Page: 1 2 3 4 5 6 ... 26  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase